All Stories

  1. The #VisualAbstract: just a pretty picture?
  2. Simulation in Urological Training and Education (SIMULATE): Protocol and curriculum development of the first multicentre international randomized controlled trial assessing the transferability of simulation-based surgical training
  3. The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis
  4. A comparative analysis of single port versus multi-port robotic assisted radical prostatectomy for prostate cancer
  5. 3D printing technology and its role in urological training
  6. #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
  7. European Association of Urology Section of Urolithiasis (EULIS) Consensus Statement on Simulation, Training, and Assessment in Urolithiasis
  8. The Internet of Skills: use of fifth-generation telecommunications, haptics and artificial intelligence in robotic surgery
  9. Three-dimensional printing in robot-assisted radical prostatectomy - an Idea, Development, Exploration, Assessment, Long-term follow-up (IDEAL) Phase 2a study
  10. The role of cognitive training in endourology: A randomized controlled trial
  11. Conversion of Robot-assisted Partial Nephrectomy to Radical Nephrectomy: A Prospective Multi-institutional Study
  12. The Effect of Visual-Spatial Ability on the Learning of Robot-Assisted Surgical Skills
  13. New surgical robots on the horizon and the potential role of artificial intelligence
  14. Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review
  15. National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer
  16. Validation of the Advanced Scope Trainer for Flexible Ureterorenoscopy Training
  17. National cohort study comparing severe medium-term urinary complications after robot-assisted vs laparoscopic vs retropubic open radical prostatectomy
  18. Robotic Partial nephrectomy in Solitary Kidney in a multi-institutional setting
  19. Cognitive training: How can it be adapted for surgical education?
  20. Development of a patient and institutional-based model for estimation of operative times for robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium
  21. Nontechnical skill training and the use of scenarios in modern surgical education
  22. Training Tools for Nontechnical Skills for Surgeons—A Systematic Review
  23. Robot-assisted vs open radical prostatectomy: the day after
  24. Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
  25. Training, assessment and accreditation in surgery
  26. Cytoreductive nephrectomy in the era of targeted therapies: a review
  27. Ex vivo study of prostate cancer localization using rolling mechanical imaging towards minimally invasive surgery
  28. Precision surgery and genitourinary cancers
  29. Modular Training for Robot-Assisted Radical Prostatectomy: Where to Begin?
  30. Future of robotic surgery in urology
  31. PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells
  32. Palpation force modulation strategies to identify hard regions in soft tissue organs
  33. Weighing the evidence from surgical trials
  34. Use of Main Renal Artery Clamping Predominates Over Minimal Clamping Techniques During Robotic Partial Nephrectomy for Complex Tumors
  35. Training Modalities in Robot-assisted Urologic Surgery: A Systematic Review
  36. The future of robotics
  37. Competency based training in robotic surgery: benchmark scores for virtual reality robotic simulation
  38. The effectiveness of Google GLASS as a vital signs monitor in surgery: A simulation study
  39. The role of simulation in urological training – A quantitative study of practice and opinions
  40. Is extended pelvic lymph node dissection for prostate cancer the only recommended option? A systematic over-view of the literature
  41. Fournier’s gangrene. A clinical review
  42. A review of wearable technology in medicine
  43. Intracellular C3a regulates cell proliferation in prostate epithelial cells
  44. Clarifying the PSA grey zone: The management of patients with a borderline PSA
  45. PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database
  46. Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
  47. Simulation-based training and assessment in urological surgery
  48. Immune checkpoint blockade - a treatment for urological cancers?
  49. Randomised controlled trials in robotic surgery
  50. Current Status of Simulation and Training Models in Urological Surgery: A Systematic Review
  51. Getting personal with prostate cancer: DNA-repair defects and olaparib in metastatic prostate cancer
  52. Morphological Computation of Haptic Perception of a Controllable Stiffness Probe
  53. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy
  54. Towards safer obstacle avoidance for continuum-style manipulator in dynamic environments
  55. Laparoendoscopic single-site donor nephrectomy (LESS-DN) versus standard laparoscopic donor nephrectomy
  56. Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2
  57. Regulatory T Cells
  58. Final robotic frontier: the evolution and current state of robot-assisted radical cystectomy
  59. The Role of Simulation in Surgical Training
  60. Structured and Modular Training Pathway for Robot-assisted Radical Prostatectomy (RARP): Validation of the RARP Assessment Score and Learning Curve Assessment
  61. Validation of the RobotiX Mentor Robotic Surgery Simulator
  62. Salient Feature of Haptic-Based Guidance of People in Low Visibility Environments Using Hard Reins
  63. Training in minimally invasive surgery in urology: European Association of Urology/International Consultation of Urological Diseases consultation
  64. Robot-assisted partial nephrectomy in cystic tumours: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database
  65. Holmium Laser Enucleation of the Prostate: Simulation-Based Training Curriculum and Validation
  66. The Relationship Between Technical And Nontechnical Skills Within A Simulation-Based Ureteroscopy Training Environment
  67. Pilot Validation Study of the European Association of Urology Robotic Training Curriculum
  68. Identification of Haptic Based Guiding Using Hard Reins
  69. A Novel Cadaveric Simulation Program in Urology
  70. Learning fromThe Lancet
  71. Effective non-technical skills are imperative to robot-assisted surgery
  72. Simulation‐based training for prostate surgery
  73. Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts
  74. Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review
  75. Full immersion simulation: validation of a distributed simulation environment for technical and non-technical skills training in Urology
  76. Modeling and Optimizing Output Characteristics of Intensity Modulated Optical Fiber-Based Displacement Sensors
  77. Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies
  78. An assessment of the physical impact of complex surgical tasks on surgeon errors and discomfort: a comparison between robot‐assisted, laparoscopic and open approaches
  79. An over-view of robot assisted surgery curricula and the status of their validation
  80. Simulation-Based Ureteroscopy Training: A Systematic Review
  81. Image guided robotic surgery: Current evidence for effectiveness in urology
  82. Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants
  83. Validation of the GreenLight™ Simulator and development of a training curriculum for photoselective vaporisation of the prostate
  84. Simulation-based ureteroscopy skills training curriculum with integration of technical and non-technical skills: a randomised controlled trial
  85. An overview of the use and implementation of checklists in surgical specialities – A systematic review
  86. Performance of technology-driven simulators for medical students—a systematic review
  87. Recurrent urinary tract infections in women
  88. Surgical Science - everything is not what it seems
  89. Systematic review of live surgical demonstrations and their effectiveness on training
  90. Multi-fingered haptic palpation using pneumatic feedback actuators
  91. Re: Hinata et al.: Novel Telementoring System for Robot-assisted Radical Prostatectomy: Impact on the Learning Curve. (Urology 2014;83:1088-92)
  92. Robotic Granular Jamming: Does the Membrane Matter?
  93. A Workflow to Improve the Alignment of Prostate Imaging with Whole-mount Histopathology
  94. Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β3-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB)
  95. Multi-fingered haptic palpation utilizing granular jamming stiffness feedback actuators
  96. Research vibrations
  97. Engaging responsibly with social media: the BJUI guidelines
  98. Re: Willem M. Brinkman, Irene M. Tjiam, Barbara M.A. Schout, et al. Results of the European Basic Laparoscopic Urological Skills examination. Eur Urol 2014;65:490–6
  99. Behavioral Characteristics of Manual Palpation to Localize Hard Nodules in Soft Tissues
  100. The granular jamming integrated actuator
  101. Efficacy of robot‐assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC)
  102. An Updated Systematic Review and Statistical Comparison of Standardised Mean Outcomes for the Use of Botulinum Toxin in the Management of Lower Urinary Tract Disorders
  103. A Review of the Available Urology Skills Training Curricula and Their Validation
  104. Face and Content Validation of the Prostatic Hyperplasia Model and Holmium Laser Surgery Simulator
  105. Role of fluorodeoxyglucose positron emission tomography (FDG PET)‐computed tomography (CT) in the staging of bladder cancer
  106. Validation of the bladder control self-assessment questionnaire (B-SAQ) in men
  107. Live surgical education: a perspective from the surgeons who perform it
  108. Analysis of Intracorporeal Compared with Extracorporeal Urinary Diversion After Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
  109. Novel Force Sensing Approach Employing Prismatic-Tip Optical Fiber Inside an Orthoplanar Spring Structure
  110. Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure
  111. International Robotic Radical Cystectomy Consortium: A way forward
  112. Quality has no boundaries
  113. CD46: The ‘multitasker’ of complement proteins
  114. Beyond our wildest dreams
  115. The use of botulinum toxin for the treatment of urologic pain
  116. The impact of the BJUI and what influences it today: does impact factor matter?
  117. Air-float Palpation Probe for Tissue Abnormality Identification During Minimally Invasive Surgery
  118. An Optimal State Dependent Haptic Guidance Controller via a Hard Rein
  119. Evaluating Manual Palpation Trajectory Patterns in Tele-manipulation for Soft Tissue Examination
  120. Inverse finite-element modeling for tissue parameter identification using a rolling indentation probe
  121. Technological Innovation in the BJUI
  122. Granular Jamming With Hydraulic Control
  123. Long-term Outcomes of Robot-assisted Radical Cystectomy for Bladder Cancer
  124. Reply from Authors re: Bernard H. Bochner. Oncologic Outcomes Achieved by Radical Cystectomy. Eur Urol 2013;64:225–6
  125. Measuring the surgical ‘learning curve’: methods, variables and competency
  126. Oncological outcomes of robotic-assisted radical prostatectomy after more than 5 years
  127. Enhanced cross-priming of naive CD8+T cells by dendritic cells treated by the IMiDs®immunomodulatory compounds lenalidomide and pomalidomide
  128. Then and now
  129. 3D-Holoscopic Imaging: A New Dimension to Enhance Imaging in Minimally Invasive Therapy in Urologic Oncology
  130. Botulinum Toxin—What Urologic Uses Does the Data Support?
  131. Development and content validation of a surgical safety checklist for operating theatres that use robotic technology
  132. Bringing science closer to urologists
  133. The European Association of Urology Robotic Urology Section (ERUS) survey of robot‐assisted radical prostatectomy (RARP)
  134. Design and the newBJUI
  135. Current State of the Art in Non-Invasive Urodynamics
  136. Evaluation of robotic and laparoscopic partial nephrectomy for small renal tumours (T1a)
  137. OnabotulinumtoxinA in Benign Prostatic Hyperplasia
  138. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
  139. Podcasts Made Simple
  140. Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC)
  141. Increasing importance of truly informed consent: the role of written patient information
  142. Changing paradigms in the investigation of an elevated PSA level
  143. Design and evaluation of an image-guidance system for robot-assisted radical prostatectomy
  144. Botulinum toxin-A for the treatment of overactive bladder: UK contributions
  145. Improved Modelling of Tool Tracking Errors by Modelling Dependent Marker Errors
  146. A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons
  147. Recent advances in the diagnosis and treatment of bladder cancer
  148. Ureteric injury: a challenging condition to diagnose and manage
  149. Introducing The Productive Operating Theatre Programme in Urology Theatre Suites
  150. The addition of the surgical robot to skin cancer management
  151. Granular jamming transitions for a robotic mechanism
  152. Tablet Based Simulation Provides a New Solution to Accessing Laparoscopic Skills Training
  153. “The most read surgical journal on the web”
  154. Learning the lessons from 1000 robot-assisted radical prostatectomy procedures
  155. CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate
  156. Design of a variable stiffness flexible manipulator with composite granular jamming and membrane coupling
  157. Prostate cancer treatment: the times they are a' changin'
  158. Development and implementation of centralized simulation training: evaluation of feasibility, acceptability and construct validity
  159. The surgeon as educator: fundamentals of faculty training in surgical specialties
  160. Overactive bladder and sexual function: a nightmare couple
  161. Miniature 3-Axis Distal Force Sensor for Minimally Invasive Surgical Palpation
  162. Focal HIFU for prostate cancer
  163. Robotic assisted radical cystectomy and urinary diversion
  164. Minimally invasive cystectomy approaches in the treatment of bladder cancer
  165. Volume Matters: Bladder Injections of Botulinum Toxin Type A
  166. Current status of robot-assisted partial nephrectomy
  167. UROLOGY APPS: A REVIEW OF ALL APPS AVAILABLE FOR UROLOGISTS
  168. The importance of obtaining truly consensual informed consent
  169. A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy
  170. Repeated Botulinum Toxin Type A Injections for Refractory Overactive Bladder: Medium-Term Outcomes, Safety Profile, and Discontinuation Rates
  171. Reply to Alchiede Simonato and Marco Ennas’ Letter to the Editor re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer with Special Emphas...
  172. Assessing the cost effectiveness of robotics in urological surgery - a systematic review
  173. Decision making in urological surgery
  174. Robotic Reconstruction Techniques Following Cystectomy
  175. Should we inject the trigone during botulinum toxin injection?
  176. INDICATORS FOR RESEARCH PERFORMANCE EVALUATION: AN OVERVIEW
  177. HOW TO AVOID THE ‘SEVEN DEADLY SINS OF SURGERY’
  178. Finite-Element Modeling of Soft Tissue Rolling Indentation
  179. Quality-of-care framework in urological cancers: where do we stand?
  180. ONCOLOGICAL OUTCOMES OF ROBOT-ASSISTED RADICAL CYSTECTOMY
  181. Urology training: past, present and future
  182. Immunotherapy of prostate cancer: identification of new treatments and targets for therapy, and role of WAP domain-containing proteins
  183. Contemporary Management of Lower Urinary Tract Disease With Botulinum Toxin A: A Systematic Review of Botox (OnabotulinumtoxinA) and Dysport (AbobotulinumtoxinA)
  184. OnabotulinumtoxinA in Refractory Neurogenic Detrusor Overactivity
  185. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer With Special Emphasis on Cancer Control and Complications
  186. Demonstration of erectile management techniques to men scheduled for radical prostatectomy reduces long-term regret: a comparative cohort study
  187. How to develop a simulation programme in urology
  188. What is the current status of revalidation in urology?
  189. Overcoming the challenges of robot-assisted radical prostatectomy
  190. Effectiveness of Procedural Simulation in Urology: A Systematic Review
  191. MENTORSHIP PROGRAMMES FOR LAPAROSCOPIC AND ROBOTIC UROLOGY
  192. EDUCATIONAL RESEARCH IN UROLOGY: CURRENT STATUS AND FUTURE CHALLENGES
  193. The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial
  194. How can we ensure lifelong learning for urological specialists?
  195. One hand is better than two: conversion from pure laparoscopic to the hand-assisted approach during difficult nephrectomy
  196. Reply
  197. ‘MOHS SURGERY OF THE PROSTATE’: THE UTILITY OF IN SITU FROZEN SECTION ANALYSIS DURING ROBOTIC PROSTATECTOMY
  198. Face, content and construct validity of a virtual reality simulator for robotic surgery (SEP Robot)
  199. GETTING TO A BETTER “PLACE”: HELPING PATIENTS COUNTER OBESITY BY ACHIEVING ENDURING LIFESTYLE CHANGE
  200. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxina in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder
  201. Analysis of Early Complications of Robotic-assisted Radical Cystectomy Using a Standardized Reporting System
  202. Lymphadenectomy at the time of robot‐assisted radical cystectomy: results from the International Robotic Cystectomy Consortium
  203. REDUCING THE TIME TO CONTINENCE AFTER RADICAL PROSTATECTOMY
  204. FLEXIBLE ROBOTICS
  205. Role of laparoscopic nephrectomy for refractory hypertension in poorly functioning kidneys
  206. ROBOTIC PARTIAL NEPHRECTOMY IN THE SETTING OF PRIOR ABDOMINAL SURGERY
  207. Immunohistochemical Expression of Muscarinic Receptors in the Urothelium and Suburothelium of Neurogenic and Idiopathic Overactive Human Bladders, and Changes With Botulinum Neurotoxin Administration
  208. Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity
  209. LEADERSHIP IN UROLOGY EDUCATION
  210. AVOIDING AND DEALING WITH THE COMPLICATIONS OF ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY
  211. LIVE SURGICAL DEMONSTRATIONS IN UROLOGY: VALUABLE EDUCATIONAL TOOL OR PUTTING PATIENTS AT RISK?
  212. Does Previous Robot-assisted Radical Prostatectomy Experience Affect Outcomes at Robot-assisted Radical Cystectomy? Results from the International Robotic Cystectomy Consortium
  213. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity
  214. ROBOTIC RECONSTRUCTIVE UROLOGY: POSSIBILITIES FOR THE UROLOGICAL SURGEON BEYOND THE PROSTATE
  215. Current status of robotic partial nephrectomy
  216. Face, content and construct validation of the first virtual reality laparoscopic nephrectomy simulator
  217. The Learning Curve of Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
  218. Reply from Authors re: Urs E. Studer, Laurence Collette. Robot-Assisted Cystectomy: Does It Meet Expectations? Eur Urol 2010;58:203–4
  219. An analysis of intraoperative versus post-operative dosimetry with CT, CT–MRI fusion and XMR for the evaluation of permanent prostate brachytherapy implants
  220. Surgical Margin Status After Robot Assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium
  221. Corrigendum to “Anatomic Considerations During Radical Prostatectomy” [Eur. Urol. 2010;57:193–5]
  222. Assessment and maintenance of competence in urology
  223. Complete Continence after Botulinum Neurotoxin Type A Injections for Refractory Idiopathic Detrusor Overactivity Incontinence: Patient-Reported Outcome at 4 Weeks
  224. TRANSMEMBRANE PROTEASE SERINE 2 IN PROSTATE CANCER
  225. An indentation depth—force sensing wheeled probe for abnormality identification during minimally invasive surgery
  226. Durability of treatments for overactive bladder
  227. Repeated Injections of Botulinum Toxin-A for Idiopathic Detrusor Overactivity
  228. Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin
  229. Anatomic Considerations During Radical Prostatectomy
  230. Rolling Mechanical Imaging for Tissue Abnormality Localization During Minimally Invasive Surgery
  231. Urethral diverticular carcinoma: an overview of current trends in diagnosis and management
  232. THE SCIENCE BEHIND HAPTICS IN ROBOTIC UROLOGICAL SURGERY
  233. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial
  234. Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment
  235. What a Patient With Refractory Idiopathic Detrusor Overactivity Should Know About Botulinum Neurotoxin Type A Injection
  236. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
  237. PATIENT PERCEPTION OF ROBOTIC UROLOGY
  238. SINGLE-INCISION LAPAROSCOPIC SURGERY
  239. Outcomes of robotic assisted radical prostatectomy
  240. Retrograde ejaculation following open ureteric reimplantation: a case report
  241. The current status of robot-assisted radical prostatectomy
  242. Successful Salvage Robotic-Assisted Radical Prostatectomy After External Beam Radiotherapy Failure
  243. Robotic assisted radical cystectomy: short to medium-term oncologic and functional outcomes
  244. Robotic-assisted Laparoscopic Radical Cystectomy with Extracorporeal Urinary Diversion: Initial Experience
  245. Robotic-assisted radical cystectomy
  246. ROBOT-ASSISTED PARTIAL NEPHRECTOMY
  247. Wheel/tissue force interaction: A new concept for soft tissue diagnosis during MIS
  248. Early Effect on the Overactive Bladder Symptoms following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity
  249. Robotically assisted laparoscopic pyeloplasty
  250. Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin Type A for the Treatment of Neurogenic or Idiopathic Detrusor Overactivity
  251. ROBOTICALLY ASSISTED RADICAL CYSTECTOMY
  252. Urodynamic Assessment of Poor Responders After Botulinum Toxin-A Treatment for Overactive Bladder
  253. Ablative and reconstructive robotic-assisted laparoscopic renal surgery
  254. Robotics in Urology
  255. Laparoscopic upper urinary tract surgery for benign and malignant conditions. Does aetiology have an effect on health-related quality of life?*
  256. Robotic Colposuspension: Two Case Reports
  257. Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going
  258. The management of postoperative hemorrhage after laparoscopic renal and adrenal surgery
  259. Successful treatment with botulinum toxin A after failed augmentation ileocystoplasty
  260. Laparoscopic Nephrectomy in a Patient with Ankylosing Spondylitis: Surgical and Anesthetic Challenges
  261. Is botulinum A toxin an effective treatment for idiopathic detrusor overactivity and sensory urgency?
  262. IMPROVING PROSTATE BRACHYTHERAPY BY DEVELOPING IMAGE GUIDANCE
  263. Ergonomics in minimally invasive surgery
  264. Botulinum injections for the treatment of bladder symptoms of multiple sclerosis
  265. Cystine calculi: challenging group of stones
  266. Minimally invasive radical cystectomy
  267. Proposed Mechanism for the Efficacy of Injected Botulinum Toxin in the Treatment of Human Detrusor Overactivity
  268. Percutaneous Renal Surgery: A Pioneering Perspective
  269. Laparoscopic pyeloplasty and pyelopyelostomy for ureteropelvic junction obstruction in a duplicated collecting system
  270. Is botulinum toxin type A a safe and effective treatment for neurogenic urinary incontinence?
  271. A COMPARISON BETWEEN THE RESPONSE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND NEUROGENIC DETRUSOR OVERACTIVITY TO THE FIRST INTRADETRUSOR INJECTION OF BOTULINUM-A TOXIN
  272. DECREASED SENSORY RECEPTORS P2X 3 AND TRPV1 IN SUBUROTHELIAL NERVE FIBERS FOLLOWING INTRADETRUSOR INJECTIONS OF BOTULINUM TOXIN FOR HUMAN DETRUSOR OVERACTIVITY
  273. Laparoscopic Management of Cryptorchidism in Adults
  274. Multimodal management of urolithiasis in renal transplantation
  275. Follow-up of polytetrafluoroethylene arteriovenous fistulae for haemodialysis
  276. Embolization of a Bleeding Renal Angiomyolipoma in Pregnancy: Case Report and Review
  277. Laparoscopic reconstructive urology
  278. Groin abscess: a vesico-cutaneous fistula to the groin. A rare complication of open prostatectomy
  279. Laparoscopic ureteroneocystostomy for benign lower ureteric stricture: case study and literature review
  280. Botulinum toxin: A new dimension in the treatment of lower urinary tract dysfunction
  281. Flexible ureterorenoscopy: prospective analysis of the Guy's experience
  282. Percutaneous nephrolithotomy in early pregnancy
  283. Prolonging the life of the flexible ureterorenoscope
  284. Laparoscopic Nephroureterectomy for Adult Incontinence Caused by Functioning Ectopic Pelvic Kidney Draining into Vagina
  285. Pseudoaneurysm formation after flexible ureterorenoscopy and electrohydraulic lithotripsy
  286. Long-term Outcomes of Brachiobasilic Transposition Fistula for Haemodialysis
  287. Prospective Experience with a Second-Generation Hand-Assisted Laparoscopic Device and Comparison with First-Generation Devices
  288. Management of encrusted ureteral stents impacted in upper tract
  289. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity
  290. Lower ureteric obstruction: a complication of tailed ureteric stents
  291. Radical prostatectomy in Britain and Ireland at the millennium